Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Charlotte Guyader"'
Autor:
Nora M. Gerhards, Vincent A. Blomen, Merve Mutlu, Joppe Nieuwenhuis, Denise Howald, Charlotte Guyader, Jos Jonkers, Thijn R. Brummelkamp, Sven Rottenberg
Publikováno v:
Molecular Oncology, Vol 12, Iss 6, Pp 953-971 (2018)
The absence of biomarkers to accurately predict anticancer therapy response remains a major obstacle in clinical oncology. We applied a genome‐wide loss‐of‐function screening approach in human haploid cells to characterize genetic vulnerabiliti
Externí odkaz:
https://doaj.org/article/339adfac45064622b560e496f404b599
Autor:
Charlotte Guyader, Jocelyn Céraline, Eléonore Gravier, Aurélie Morin, Sandrine Michel, Eva Erdmann, Gonzague de Pinieux, Florence Cabon, Jean-Pierre Bergerat, Marie-France Poupon, Stéphane Oudard
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e42252 (2012)
Almost all prostate cancers respond to androgen deprivation treatment but many recur. We postulated that risk of hormone escape--frequency and delay--are influenced by hormone therapy modalities. More, hormone therapies induce crucial biological chan
Externí odkaz:
https://doaj.org/article/016adeccd2a946a48f4e309746b64bce
Autor:
Sven Rottenberg, Piet Borst, Jos Jonkers, Rinske Drost, Wendy Sol, Aslι Küçükosmanoğlu, Ariena Kersbergen, Maaike Gonggrijp, Charlotte Guyader, Sohvi Blatter, Marina Pajic
Figure S1: Treatment response to cisplatin spread over several days. Figure S2: Cisplatin adducts in tumor remants; GFP-marker in the BRCA1-deficient mouse model. Figure S3: EdU incorporation assay. Figure S4: Genomic profile and clonogenic assays of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7531a3c64b1329c1d24fd7cd77edd949
https://doi.org/10.1158/1078-0432.22462070
https://doi.org/10.1158/1078-0432.22462070
Autor:
Aslι Küçükosmanoğlu, Sven Rottenberg, Maaike Gonggrijp, Rinske Drost, Piet Borst, Charlotte Guyader, Sohvi Blatter, Marina Pajic, Jos Jonkers, Ariena Kersbergen, Wendy Sol
Publikováno v:
Clinical Cancer Research
Clinical Cancer Research, 23(22), 7020-7033. American Association for Cancer Research Inc.
Pajic, M, Blatter, S, Guyader, C, Gonggrijp, M, Kersbergen, A, Küçükosmanoğlu, A, Sol, W, Drost, R, Jonkers, J, Borst, P & Rottenberg, S 2017, ' Selected alkylating agents can overcome drug tolerance of G 0-like tumor cells and eradicate BRCA1-deficient mammary tumors in mice ', Clinical Cancer Research, vol. 23, no. 22, pp. 7020-7033 . https://doi.org/10.1158/1078-0432.CCR-17-1279
Clinical Cancer Research, 23(22), 7020-7033. American Association for Cancer Research Inc.
Pajic, M, Blatter, S, Guyader, C, Gonggrijp, M, Kersbergen, A, Küçükosmanoğlu, A, Sol, W, Drost, R, Jonkers, J, Borst, P & Rottenberg, S 2017, ' Selected alkylating agents can overcome drug tolerance of G 0-like tumor cells and eradicate BRCA1-deficient mammary tumors in mice ', Clinical Cancer Research, vol. 23, no. 22, pp. 7020-7033 . https://doi.org/10.1158/1078-0432.CCR-17-1279
Purpose: We aimed to characterize and target drug-tolerant BRCA1-deficient tumor cells that cause residual disease and subsequent tumor relapse. Experimental Design: We studied responses to various mono- and bifunctional alkylating agents in a geneti
Autor:
Darius Lutter, Charlotte Guyader, S. Momsen Reincke, Deborah A Elger, Felizia K. Voss, Florian Ullrich, Vincent A. Blomen, Thomas J. Jentsch, Asli Kucukosmanoglu, Sven Rottenberg, Piet Borst, Daniel J. Vis, Guotai Xu, Lodewyk F. A. Wessels, Tobias Stauber, Thijn R. Brummelkamp, Nora M. Gerhards, Rosa Planells-Cases
Publikováno v:
The EMBO journal, 34(24): 2985-3073
The EMBO Journal
EMBO Journal, 34(24), 2993-3008. Wiley-Blackwell
ResearcherID
Planells-Cases, Rosa; Lutter, Darius; Guyader, Charlotte; Gerhards, Nora Merete; Ullrich, Florian; Elger, Deborah A; Kucukosmanoglu, Asli; Xu, Guotai; Voss, Felizia K; Reincke, S Momsen; Stauber, Tobias; Blomen, Vincent A; Vis, Daniel J; Wessels, Lodewyk F; Brummelkamp, Thijn R; Borst, Piet; Rottenberg, Sven; Jentsch, Thomas J (2015). Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt-based anti-cancer drugs. The EMBO Journal, 34(24), pp. 2993-3008. EMBO Press 10.15252/embj.201592409
Planells-Cases, R, Lutter, D, Guyader, C, Gerhards, N M, Ullrich, F, Elger, D A, Kucukosmanoglu, A, Xu, G, Voss, F K, Reincke, S M, Stauber, T, Blomen, V A, Vis, D J, Wessels, L F, Brummelkamp, T R, Borst, P, Rottenberg, S & Jentsch, T J 2015, ' Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt-based anti-cancer drugs ', EMBO Journal, vol. 34, no. 24, pp. 2993-3008 . https://doi.org/10.15252/embj.201592409
EMBO JOURNAL
The EMBO Journal
EMBO Journal, 34(24), 2993-3008. Wiley-Blackwell
ResearcherID
Planells-Cases, Rosa; Lutter, Darius; Guyader, Charlotte; Gerhards, Nora Merete; Ullrich, Florian; Elger, Deborah A; Kucukosmanoglu, Asli; Xu, Guotai; Voss, Felizia K; Reincke, S Momsen; Stauber, Tobias; Blomen, Vincent A; Vis, Daniel J; Wessels, Lodewyk F; Brummelkamp, Thijn R; Borst, Piet; Rottenberg, Sven; Jentsch, Thomas J (2015). Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt-based anti-cancer drugs. The EMBO Journal, 34(24), pp. 2993-3008. EMBO Press 10.15252/embj.201592409
Planells-Cases, R, Lutter, D, Guyader, C, Gerhards, N M, Ullrich, F, Elger, D A, Kucukosmanoglu, A, Xu, G, Voss, F K, Reincke, S M, Stauber, T, Blomen, V A, Vis, D J, Wessels, L F, Brummelkamp, T R, Borst, P, Rottenberg, S & Jentsch, T J 2015, ' Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt-based anti-cancer drugs ', EMBO Journal, vol. 34, no. 24, pp. 2993-3008 . https://doi.org/10.15252/embj.201592409
EMBO JOURNAL
Although platinum‐based drugs are widely used chemotherapeutics for cancer treatment, the determinants of tumor cell responsiveness remain poorly understood. We show that the loss of subunits LRRC8A and LRRC8D of the heteromeric LRRC8 volume‐regu
Autor:
Charlotte Guyader, Ariena Kersbergen, Nadine Stokar-Regenscheit, Sven Rottenberg, Sohvi Blatter
Publikováno v:
Journal of Molecular and Clinical Medicine. 1
Autor:
Jos Jonkers, Merve Mutlu, Charlotte Guyader, Thijn R. Brummelkamp, Sven Rottenberg, Denise Howald, Vincent A. Blomen, Nora M. Gerhards, Joppe Nieuwenhuis
Publikováno v:
Molecular Oncology
Molecular Oncology, Vol 12, Iss 6, Pp 953-971 (2018)
Gerhards, Nora Merete; Blomen, Vincent A; Mutlu, Merve; Nieuwenhuis, Joppe; Howald, Denise; Guyader, Charlotte; Jonkers, Jos; Brummelkamp, Thijn R; Rottenberg, Sven (2018). Haploid genetic screens identify genetic vulnerabilities to microtubule-targeting agents. Molecular oncology, 12(6), pp. 953-971. Elsevier 10.1002/1878-0261.12307
Molecular Oncology, Vol 12, Iss 6, Pp 953-971 (2018)
Gerhards, Nora Merete; Blomen, Vincent A; Mutlu, Merve; Nieuwenhuis, Joppe; Howald, Denise; Guyader, Charlotte; Jonkers, Jos; Brummelkamp, Thijn R; Rottenberg, Sven (2018). Haploid genetic screens identify genetic vulnerabilities to microtubule-targeting agents. Molecular oncology, 12(6), pp. 953-971. Elsevier 10.1002/1878-0261.12307
The absence of biomarkers to accurately predict anticancer therapy response remains a major obstacle in clinical oncology. We applied a genome-wide loss-of-function screening approach in human haploid cells to characterize genetic vulnerabilities to
Autor:
Marina, Pajic, Sohvi, Blatter, Charlotte, Guyader, Maaike, Gonggrijp, Ariena, Kersbergen, Aslι, Küçükosmanoğlu, Wendy, Sol, Rinske, Drost, Jos, Jonkers, Piet, Borst, Sven, Rottenberg
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 23(22)
Autor:
Marie-Emmanuelle Legrier, Charlotte Guyader, Jocelyn Céraline, Nathalie Auger, Marie-France Poupon, Bernard Dutrillaux, Stéphane Oudard
Publikováno v:
International Journal of Cancer. 124:1103-1111
Lack of hormone dependency in prostate cancers is an irreversible event that occurs through generation of genomic instability induced by androgen deprivation. Indeed, the cytogenetic profile of hormone-dependent (HD) prostate cancer remains stable as
Autor:
Bernard Dutrillaux, Stéphane Oudard, M.F. Poupon, P. de Cremoux, Marie-Emmanuelle Legrier, G de Pinieux, Charlotte Guyader, J.G. Judde, Karine Boyé
Publikováno v:
British Journal of Cancer
Antitumour activity of docetaxel (Taxotere®) in hormone-dependent (HD) and hormone-independent (HID) prostate cancer PAC120 xenograft model was previously reported, and its level was associated with HER2 protein expression. In the present study, we